Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
- PMID: 31759225
- PMCID: PMC7237330
- DOI: 10.1016/j.cbpa.2019.10.004
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
Abstract
Photodynamic therapy (PDT) is an approved medical technique to treat certain forms of cancer. It has been used to complement traditional anticancer modalities such as surgery, chemotherapy or radiotherapy, and in certain cases, to replace these treatments. One critical parameter of PDT is the photosensitizer (PS); historically, a purely organic macrocyclic tetrapyrrole-based structure. This short review surveys two recent clinical examples of metal complexes, namely TOOKAD®-Soluble and TLD-1433, which have ideal photophysical properties to act as PDT PSs. We highlight the important role played by the metal ions in the PS for PDT activity.
Keywords: Bioinorganic chemistry; Medicinal inorganic chemistry; Metals in medicine; Photodynamic therapy; Photosensitizer.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest statement Theralase licenses the exclusive worldwide rights for TLD-1433 and its associated PDCs.
Figures
References
-
- Kostron H, Hasan T: Photodynamic medicine: From bench to clinic. Royal Society of Chemistry, Cambridge, UK (2016).
-
- Bonnett R: Chemical aspects of photodynamic therapy. Gordon and Breach Science Publishers, London and Newark: (2000).
-
- Henderson BW, Dougherty TJ: Photodynamic therapy: Basic principles and clinical applications. CRC Press, (1992).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
